Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04982224
Title Study of REGN5093-M114 (METxMET Antibody-Drug Conjugate) in Adult Patients With Mesenchymal Epithelial Transition Factor (MET) Overexpressing Advanced Cancer
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Regeneron Pharmaceuticals
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
University of California Irvine Medical Center (UCIMC) RECRUITING Irvine California 92617 United States Details
University of Colorado Hospital - Anschutz Cancer Pavilion (ACP) WITHDRAWN Aurora Colorado 80045 United States Details
John Hopkins RECRUITING Baltimore Maryland 21231 United States Details
Johns Hopkins Satellite Site RECRUITING Baltimore Maryland 21231 United States Details
Dana Farber Cancer Institute RECRUITING Boston Massachusetts 02215 United States Details
Henry Ford Hospital RECRUITING Detroit Michigan 48202 United States Details
NYU Langone Medical Center WITHDRAWN New York New York 10012 United States Details
Memorial Sloan Kettering Cancer Center RECRUITING New York New York 10065 United States Details
University of Pittsburgh Medical Center - Hillman Cancer Center RECRUITING Pittsburgh Pennsylvania 15232 United States Details
Medical University of South Carolina (MUSC) WITHDRAWN Charleston South Carolina 29425 United States Details
The University of Texas MD Anderson Cancer Center RECRUITING Houston Texas 77030 United States Details
Virginia Cancer Specialist RECRUITING Fairfax Virginia 22031 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field